Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Rank in Stocks #25697
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Share Price
$2.09
Last synced: 2022-03-21
Market Cap
$47.04M
Change (1 day)
-0.48%
Change (1 year)
0.00%
Country
US
Trade Recro Pharma, Inc. (REPH)

Category

Stock price history for Recro Pharma, Inc. (REPH)
Highest end of day price: $1.92 on 2022-03-01

Lowest end of day price: $8.10 on 2014-03-01
Stock price history of Recro Pharma, Inc. from 2014 to 2026
Annual Stock Price Performance
Year Performance
2022 23.15%
2021 -43.90%
2020 -83.97%
2019 139.49%
2018 -25.26%
2017 33.81%
2016 -16.69%
2015 218.14%
2014 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$163.75 27.60%
DE
$37.64 23.17%
JP
$220.05 30.36%
CH
$21.01 11.83%
IN